[Federal Register Volume 65, Number 81 (Wednesday, April 26, 2000)]
[Notices]
[Pages 24458-24459]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-10318]


=======================================================================
-----------------------------------------------------------------------

CONSUMER PRODUCT SAFETY COMMISSION


Notice of Meeting of Chronic Hazard Advisory Panel on Diisononyl 
Phthalate (DINP)

AGENCY: Consumer Product Safety Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Commission announces the first meeting of the Chronic 
Hazard Advisory Panel (CHAP) on diisononyl phthalate (DINP). The 
Commission appointed this CHAP to advise the Commission on any chronic 
hazards of cancer, birth defects, and gene mutations associated with 
children's products containing DINP.

DATES: The meeting will be held from 8:30 am to 5:00 pm on May 10 and 
from 8:30 am to 4:00 pm on May 11, 2000.

ADDRESSES: The meeting will be held in the fourth floor hearing room in 
the Commission's offices at 4330 East-West Highway, Bethesda, Maryland.

FOR FURTHER INFORMATION CONTACT: Marilyn Wind, Directorate for Health 
Sciences, Consumer Product Safety Commission, Washington, DC 20207;

[[Page 24459]]

telephone (301) 504-0477, ext. 1205; email.

SUPPLEMENTARY INFORMATION: The Commission has been concerned with 
potential risks posed to children under 3 years of age by the 
plasticizer diisononyl phthalate (DINP), which is used to soften some 
children's teethers, rattles, and toys made from polyvinyl chloride 
(PVC). DINP can leach from such products when they are mouthed by 
children, causing some DINP to be ingested. DINP has been shown to 
cause liver and other organ toxicity in laboratory animals. The 
Commission has also received a petition (No. HP 99-1) from the National 
Environmental Trust and eleven other organizations asking that the 
Commission ban PVC in children's products.
    The Commission appointed a seven-member CHAP to evaluate the 
existing scientific information regarding the mechanism by which DINP 
may cause cancer and the implications of this on the potential cancer 
risk to children. The CHAP members were selected from scientists 
recommended by the National Academy of Sciences. See 15 U.S.C. 2077, 
2030(b).
    The first meeting of the CHAP on DINP will be held on May 10 and 
11, 2000, in the fourth floor hearing room at the Commission's offices 
at 4330 East-West Highway, Bethesda, Maryland. The meeting will begin 
at 8:30 am both days and is scheduled to end at 5:00 pm on May 10 and 
4:00 pm on May 11.
    The meeting is open to the public, space permitting, but no 
opportunity for public participation in the meeting is scheduled. Such 
participation shall be permitted only in the discretion of the Chairman 
of the CHAP. There will be an opportunity in connection with the second 
meeting of the CHAP for presentation of oral and written data and views 
(date to be announced).
    At the first CHAP meeting, the CHAP will choose its Chair and Vice 
Chair and the CPSC staff will present information on the history of the 
DINP project, the provisions of the Federal Hazardous Substances Act, 
the CPSC's Chronic Hazard Guidelines, the CPSC staff's toxicity review 
and risk assessment for DINP, and other work in progress on DINP. 
During the remainder of the meeting, the CHAP will consider how it will 
proceed and begin its deliberations.

    Dated: April 20, 2000.
Sayde E. Dunn,
Secretary, Consumer Product Safety Commission.
[FR Doc. 00-10318 Filed 4-25-00; 8:45 am]
BILLING CODE 6355-01-P